Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses
Sofia Tousa,Maria Semitekolou,Ioannis Morianos,Aggelos Banos,Aikaterini I. Trochoutsou,Tess M. Brodie,Nikolaos Poulos,Konstantinos Samitas,Maria Kapasa,Dimitris Konstantopoulos,Giannis Paraskevopoulos,Mina Gaga,Catherine M. Hawrylowicz,Federica Sallusto,Georgina Xanthou
DOI: https://doi.org/10.1073/pnas.1616942114
IF: 11.1
2017-03-20
Proceedings of the National Academy of Sciences
Abstract:Significance Here, we demonstrate that the cytokine activin-A instructs the differentiation of human IL-10–producing type 1 regulatory T (Tr1)-like cells that exhibit strongly suppressive functions against allergen-induced naive and effector CD4 + T-cell responses. In addition, we show that activin-A induces the activation of interferon regulatory factor (IRF4), which, along with aryl hydrocarbon receptor (AhR) and its binding partner, AhR nuclear translocator, forms a tripartite transcription factor complex that is essential for the differentiation and effector functions of human Tr1 cells. Importantly, administration of human activin-A–induced Tr1 cells in a humanized model of asthma confers protection against cardinal disease manifestations in preventive and therapeutic regimes. Collectively, our studies unravel a biological function for activin-A in the generation of suppressive human Tr1 cells that may be exploited for the control of allergic diseases.
multidisciplinary sciences